Download | < Back |
05 Feb 2021 | |
NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve Unaudited Standalone Financial Results of the Company for the Quarter ended on 31st December, 2020<BR> <BR> Pursuant to Company's Code of Conduct and Prevention of Insider Trading, the Trading Window for the insiders is closed till 48 hours of publication of the Financial Results | |
View all announcements for NORRIS MEDICINES LTD. | Source: BSE India |